Duloxetine HCL DR Capsules
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D219R0052
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Ryan Guarnere ryan.guarnere@dla.mil (445) 737-1729
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is seeking offers for Duloxetine HCL DR Capsules through Solicitation SPE2D2-19-R-0052. The agency is procuring these pharmaceutical products for potential five-year contracts to supply the DLA, VA, Bureau of Prisons, and Indian Health Service through their Pharmaceutical Prime Vendor programs. Key requirements include unit-of-use packaging with child-proof closures, barcode labeling, quarterly sales reporting, and a 0.5% cost recovery fee. The response deadline is February 18, 2020 by 3:00 PM.
This solicitation does not use any set-asides. The current incumbent contractor is Golden State Medical Supply, Inc., who has an existing contract SPE2D2-20-D-0098 with the agency. The estimated annual quantities range from 310,927 to 629,382 capsules across the various product strengths and package sizes. The place of performance will be at the contractor's facilities.
Notice text
6 versions
Update #6 · Latest ·
Modification P00008 to Invoke Option Year 4 for the Duloxetine HCL DR National Contract SPE2D2-20-D-0098.
Update #5 ·
Modification P00001 to Invoke Option Year 1 for the Duloxetine HCL DR National Contract SPE2D2-20-D-0098.
Amendment 0003 SPE2D219R0052 dated 02/11/2020 to add Delayed Release (DR) to the drug name for line items 0004 and 0005 on the Schedule of Supply page 2 of 76 of the solicitation. See attached amendment 0003 and updated Schedule of Supply attachment.
Amendment 0002 SPE2D219R0052 dated 02/10/2020 revising closing date to reflect February 18, 2020 at 3:00 PM EST I/L/O February 11, 2020 at 3:00 PM EST.
Amendment 0001 SPE2D219R0052 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Duloxetine HCL DR Capsules SPE2D2-19-R-0052.
Update #4 ·
Amendment 0003 SPE2D219R0052 dated 02/11/2020 to add Delayed Release (DR) to the drug name for line items 0004 and 0005 on the Schedule of Supply page 2 of 76 of the solicitation. See attached amendment 0003 and updated Schedule of Supply attachment.
Amendment 0002 SPE2D219R0052 dated 02/10/2020 revising closing date to reflect February 18, 2020 at 3:00 PM EST I/L/O February 11, 2020 at 3:00 PM EST.
Amendment 0001 SPE2D219R0052 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Duloxetine HCL DR Capsules SPE2D2-19-R-0052.
Update #3 ·
Amendment 0002 SPE2D219R0052 dated 02/10/2020 revising closing date to reflect February 18, 2020 at 3:00 PM EST I/L/O February 11, 2020 at 3:00 PM EST.
Amendment 0001 SPE2D219R0052 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Duloxetine HCL DR Capsules SPE2D2-19-R-0052.
Update #2 ·
Amendment 0001 SPE2D219R0052 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Duloxetine HCL DR Capsules SPE2D2-19-R-0052.
Update #1 ·
Solicitation for Duloxetine HCL DR Capsules SPE2D2-19-R-0052.
Attachments
Show all 11
Notice history
| Notice | Type | Posted |
|---|---|---|
| Duloxetine HCL DR Capsules | Award Notice | |
| Duloxetine HCL DR Capsules | Solicitation | |
| Duloxetine HCL DR Capsules | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity